CBPO  China Biologic Products Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

2.83B

Vuru Grade

67.23/100

Current Price

$106.77
+0.29 (+0.27%)

Growth Price

$39.86
Overvalued by 62.67%

Stability Price

$18.56
Overvalued by 82.62%

Company Metrics

  • P/E 33.80
  • P/S 9.87
  • P/B 7.67
  • EPS 3.16
  • Cash ROIC 31.13%
  • Cash Ratio 0.67
  • Dividend 0 / N/A %
  • Avg. Vol. 253,955.00
  • Shares 26.51M
  • Market Cap. 2.83B

Company Description

China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

China Biologic Products Inc (CBPO) Short Interest Up 30.5% in January
Intercooler Financial - 3 hours ago
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) saw a large increase in short interest in the month of January.
Indus Capital Partners Llc Increased China Biologic Prods Inc (NASDAQ:CBPO) by ... - WallStreet.org
China Biologic Products, Inc. (NASDAQ:CBPO) Makes A Place In List Of Buzzing ... - Equities Focus
China Biologic Products (CBPO) Highlighted as Today's Perilous Reversal Stock
TheStreet.com - Jan 13, 2016
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Stock On Radar - China Biologic Products, Inc. (NASDAQ:CBPO) - Vanguard Tribune
China Biologic Products, Inc. (NASDAQ:CBPO) Stock Target and Ratings Update - SmallCapWired.com
Brokerages Anticipate China Biologic Products Inc (NASDAQ:CBPO) to Announce $0 ...
EMQ - Jan 18, 2016
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) has received a consensus broker rating score of 1.00 (Strong Buy) from the three analysts that cover the company, Zacks Investment Research reports.
Momentum Rating China Biologic Products, Inc. (NASDAQ:CBPO) - Enterprise Leader
5 Stocks Under Wall Street's Radar: Allegiant Travel Company (NASDAQ:ALGT ... - Stock Transcript
Zacks: China Biologic Products Inc (NASDAQ:CBPO) Given $161.50 Consensus ...
Intercooler Financial - Feb 11, 2016
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) has received a consensus broker rating score of 1.00 (Strong Buy) from the three analysts that provide coverage for the company, Zacks Investment Research reports.
China Biologic Products Inc (CBPO) Shares Gap Up After Analyst Upgrade
EMQ - Jan 9, 2016
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO)'s share price gapped up prior to trading on Friday after Deutsche Bank raised their price target on the stock from $149.00 to $162.00, MarketBeat reports.
Market View On China Biologic Products, Inc. (NASDAQ:CBPO)
Vanguard Tribune - Feb 7, 2016
Few brokerages covering China Biologic Products, Inc. (NASDAQ:CBPO) have recently released its earnings and stock price target.
China Biologic Products Inc (CBPO) Stock Rating Lowered by Zacks Investment ...
EMQ - Jan 8, 2016
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, Marketbeat.
Company Shares of China Biologic Products, Inc. (NASDAQ:CBPO) Rally 2.85%
Market Briefing - Feb 1, 2016
Shares of China Biologic Products, Inc. (NASDAQ:CBPO) appreciated by 2.85% during the past week but lost 9.96% on a 4-week basis.
China Biologic Products, Inc. (NASDAQ:CBPO) Recent Analyst Updates
Risers & Fallers - Feb 4, 2016
A number of investment brokers have recently updated their price targets on shares of China Biologic Products, Inc. (NASDAQ:CBPO).
China Biologic Products, Inc. (NASDAQ:CBPO) PT & Analyst Recommendation Review
Uptick Analyst - Feb 11, 2016
Brokerage firms monitoring company shares of China Biologic Products, Inc. (NASDAQ:CBPO) have placed a $161.5 price target on the stock in the short term.